We subsequently established a novel subgrouping of NB cells based on the co-expression of specific CD molecules in distinct cell clusters using the SPADE software, an unbiased expression density-based algorithm39, focusing on representative markers of neural crest cell development and NB progression: CD15, CD24, CD44, CD57, CD184 and TrkA. The gene discussed is CD44; the disease is neuroblastoma.